Pacer Advisors Inc. Acquires New Shares in Astrana Health, Inc. $ASTH

Pacer Advisors Inc. acquired a new position in Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 181,910 shares of the company’s stock, valued at approximately $5,157,000.

Several other hedge funds have also recently bought and sold shares of the business. Jacobs Levy Equity Management Inc. lifted its position in shares of Astrana Health by 211.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company’s stock worth $7,378,000 after buying an additional 161,580 shares during the last quarter. AXA S.A. acquired a new position in shares of Astrana Health during the 2nd quarter valued at about $3,150,000. Squarepoint Ops LLC raised its stake in shares of Astrana Health by 475.4% in the 2nd quarter. Squarepoint Ops LLC now owns 95,557 shares of the company’s stock valued at $2,377,000 after acquiring an additional 78,951 shares in the last quarter. Hussman Strategic Advisors Inc. lifted its holdings in Astrana Health by 50.0% in the 2nd quarter. Hussman Strategic Advisors Inc. now owns 126,000 shares of the company’s stock worth $3,135,000 after purchasing an additional 42,000 shares during the last quarter. Finally, Rhenman & Partners Asset Management AB lifted its holdings in Astrana Health by 26.7% in the 2nd quarter. Rhenman & Partners Asset Management AB now owns 190,000 shares of the company’s stock worth $4,727,000 after purchasing an additional 40,000 shares during the last quarter. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Trading Down 0.9%

Shares of Astrana Health stock opened at $25.18 on Tuesday. Astrana Health, Inc. has a 1 year low of $20.12 and a 1 year high of $39.97. The company’s fifty day simple moving average is $25.55 and its 200-day simple moving average is $26.68. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 132.53, a PEG ratio of 1.54 and a beta of 0.87. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The firm had revenue of $317.00 million during the quarter. As a group, sell-side analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have commented on ASTH. Barclays lowered their price target on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a report on Monday, November 24th. Needham & Company LLC began coverage on shares of Astrana Health in a report on Friday, December 12th. They set a “buy” rating and a $28.00 price objective for the company. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 22nd. BTIG Research cut their target price on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Finally, Zacks Research cut shares of Astrana Health from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Eight analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Astrana Health currently has a consensus rating of “Moderate Buy” and an average price target of $41.33.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.